Acer Therapeutics Inc. License Agreements
9 Contracts & Agreements
- Exclusive License Agreement dated as of August 28, 2023 by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AB (Filed With SEC on August 31, 2023)
- Exclusive License Agreement, dated as of April 4, 2014, by and between Acer Therapeutics Inc. and Baylor College of Medicine (Filed With SEC on May 17, 2021)
- Exclusive License Agreement, dated as of December 21, 2018, by and between Acer Therapeutics Inc. and Sanofi (Filed With SEC on August 13, 2020)
- License Agreement for Development and Exploitation, dated as of September 19, 2018, by and between Acer Therapeutics Inc. and Assistance Publique Hpitaux de Paris (Filed With SEC on November 9, 2018)
- THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on July 19, 2017)
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on July 19, 2017)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on July 19, 2017)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on July 19, 2017)
- First Amendment of Option and License Agreement (Filed With SEC on March 9, 2015)
